|
July
17, 2008
Raven's Discovery Platform in Cancer
Stem Cell Biology Enhances MacroGenics' Oncology Capabilities and Complements
Proprietary Antibody Technology Platforms
June
19. 2008
Metabasis Announces Promising Results
from Its Phase 1b Clinical Trial for MB07811, Its Novel Product Candidate
for the Treatment of Hyperlipidemia
June
16, 2008
Cytokinetics Announces Late Breaking
Trials Presentation Relating to CK-1827452 at the 2008 Heart Failure Congress
of the European Society of Cardiology
May
16, 2008
Alba Therapeutics Announces the Enrollment
and Randomization of the First Patient in the Phase IIb Clinical Trial
for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease
May
12, 2008
Intercell AG to Acquire Iomai Corporation
to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine
Innovation
April
28, 2008
Metabasis Therapeutics Announces Positive
Results in the Phase 2a Clinical Trial for MB07803, Its Product Candidate
for the Treatment of Type 2 Diabetes
April
21, 2008
Stromedix Raises $25 Million Series
B for Fibrosis Programs, Begins Clinical Trial
April
18, 2008
Nereus Pharmaceuticals Initiates Combination
Clinical Trial for Proteasome Inhibitor NPI-0052 in Solid Tumors
April
11, 2008
Maria Sainz Named President and CEO
of Concentric Medical
March
25, 2008
Anacor Pharmaceuticals Announces Positive
Results from Phase 2A Clinical Trial of AN2728 in Psoriasis Patients
|
